Rapid Antibody Tests

An antibody test looks for antibodies that are made by the immune system in response to a threat, such as a specific virus. Antibodies can help fight infections.

DEFINITION:

A rapid antibody test uses a blood sample from the fingertip to assess if you have IgM and IgG antibodies to the virus that causes COVID-19, with results available in 15 minutes.

We provide much more than the tests

Contact one of our specialists

Need to organize and implement COVID-19 testing? Our custom solution provides a full turnkey service for all of your COVID-19 testing needs. Our custom track and trace software and process are an invaluable all-in-one resource for your entire corporation, team, employees, and staff members, providing them a convenient way to schedule and track their COVID-19 tests. Our portals are custom-designed to fit the needs of your organization, providing around-the-clock COVID-19 test scheduling accessibility.

SCHEDULE A FREE CONSULTATION

AccessBio Carestart™ COVID-19 Rapid Antibody Test

This rapid test detects and differentiates IgM/IgG antibodies specific to SARS-CoV-2.

The CareStart™ COVID-19 IgM/IgG is intended for use as an aid in identifying and monitoring individuals’ previous infection history and immune response to COVID-19. This rapid test detects and differentiates IgM/IgG antibodies specific to SARS-CoV-2.

The CareStart™ COVID-19 IgM/IgG is an immunochromatographic lateral flow assay intended for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum, plasma (sodium citrate, sodium heparin, or dipotassium EDTA), and venous whole blood (sodium citrate, sodium heparin, or dipotassium EDTA).

Learn More and Order Information

Sienna COVID-19 IgG/IgM Rapid Antibody Test

The Sienna COVID-19 IgG/IgM Rapid Antibody Test are Rapid Antibody Tests which detect both IgG and IgM antibodies through a patient’s serology (blood) sample.

Antibody tests will identify whether a patient has previously contracted the COVID-19 virus and has antibodies in their blood which indicate a level of immunity to the virus.

Early after infection (usually after the first week), a class of antibodies known as immunoglobulin M (IgM) develops. Later, after the first 2-4 weeks following infection, immunoglobulin G (IgG), a more durable antibody, is produced.

Learn More and Order Information